A000640 Stock Overview
Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
Dong-A Socio Holdings Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩113,700.00 |
52 Week High | ₩121,400.00 |
52 Week Low | ₩76,800.00 |
Beta | 0.27 |
1 Month Change | -0.87% |
3 Month Change | 13.70% |
1 Year Change | 35.68% |
3 Year Change | -10.82% |
5 Year Change | 6.26% |
Change since IPO | 257.41% |
Recent News & Updates
Recent updates
Key Things To Watch Out For If You Are After Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) 0.8% Dividend
Apr 29These 4 Measures Indicate That Dong-A Socio Holdings (KRX:000640) Is Using Debt Extensively
Apr 08Are Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Mixed Financials Driving The Negative Sentiment?
Mar 18What Type Of Shareholders Own The Most Number of Dong-A Socio Holdings Co., Ltd. (KRX:000640) Shares?
Feb 25A Look At Dong-A Socio Holdings' (KRX:000640) Share Price Returns
Feb 04Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?
Jan 14Is It Smart To Buy Dong-A Socio Holdings Co., Ltd. (KRX:000640) Before It Goes Ex-Dividend?
Dec 24Dong-A Socio Holdings (KRX:000640) Takes On Some Risk With Its Use Of Debt
Dec 13Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Nov 22Shareholder Returns
A000640 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -1.6% | -1.0% | -2.4% |
1Y | 35.7% | 4.5% | 1.9% |
Return vs Industry: A000640 exceeded the KR Pharmaceuticals industry which returned 4.5% over the past year.
Return vs Market: A000640 exceeded the KR Market which returned 1.9% over the past year.
Price Volatility
A000640 volatility | |
---|---|
A000640 Average Weekly Movement | 4.0% |
Pharmaceuticals Industry Average Movement | 4.7% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A000640 has not had significant price volatility in the past 3 months.
Volatility Over Time: A000640's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1932 | 5,530 | Jae-Hun Jung | www.donga.co.kr |
Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It develops DA-1241 for the treatment of type 2 diabetes and non-alcoholic steatohepatitis; DA-1726, an oxyntomodulin analogue to treat obesity; DA-1229, a dipeptidyl peptidase-4 inhibitor class treatment for type 2 diabetes; DA-8010, a muscarinic M3 receptor antagonist for the treatment of overactive bladder; DMB-3115, a biosimilar of Stelara and an inflammatory disease treatment; DA-3880 to treat anemia; STP0404, an HIV-1 treatment drug; and STP1002, an anti-cancer drug. The company also provides healthcare solutions to customers in Bacchus, over-the-counter, consumer healthcare, and derma business areas; CDMO services; imaging equipment and ENT workstation products; mineral water under the Cheonnyeonsu brand name; and IT and construction services.
Dong-A Socio Holdings Co., Ltd. Fundamentals Summary
A000640 fundamental statistics | |
---|---|
Market cap | ₩724.46b |
Earnings (TTM) | ₩57.99b |
Revenue (TTM) | ₩1.13t |
12.3x
P/E Ratio0.6x
P/S RatioIs A000640 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A000640 income statement (TTM) | |
---|---|
Revenue | ₩1.13t |
Cost of Revenue | ₩759.33b |
Gross Profit | ₩372.67b |
Other Expenses | ₩314.68b |
Earnings | ₩57.99b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 9.28k |
Gross Margin | 32.92% |
Net Profit Margin | 5.12% |
Debt/Equity Ratio | 57.2% |
How did A000640 perform over the long term?
See historical performance and comparison